đź•’ Created · Updated

The Food and Drug Administration approves updated COVID-19 vaccines to target the XFG strain for the 2026-2027 season.

The Food and Drug Administration approved updated COVID-19 vaccines from Moderna, Pfizer, and Sanofi to target the XFG strain for the 2026-2027 season. These vaccines are designed to match the circulating recombinant omicron variant, which currently accounts for approximately 40% of U.S. cases. Medical experts emphasize that while the vaccines are most effective for high-risk groups—including those aged 65 and older, pregnant women, and the immunocompromised—they remain beneficial for healthy individuals by reducing the risk of severe disease, hospitalization, and death. The vaccines are expected to be available in pharmacies, hospitals, and clinics across the country in the coming days. While the CDC's Advisory Committee on Immunization Practices was restructured by Health and Human Services Secretary Robert F. Kennedy Jr., a federal judge stayed his appointments to the panel. Experts suggest that most insurance plans, including Medicare Part B and Medicaid, will likely cover the shots at no cost, though the specific availability for uninsured individuals depends on state and local health departments.

Sources